Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
To determine the effect of ketamine, compared to propofol, when used an an anesthetic agent
for electroconvulsive therapy (ECT) in the treatment of major depressive disorder (MDD). We
hypothesize that ketamine, compared to propofol, will improve the the symptoms of MDD when
used as the anesthetic agent to facilitate ECT. Additionally, we hypothesize the dissociative
and cardiovascular effects of ketamine will be minimal.
Phase:
Phase 4
Details
Lead Sponsor:
University of Saskatchewan
Collaborators:
Royal University Hospital Foundation Saskatoon Health Region Schulman Research Award